Injector Safety Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2009/036682, filed Mar 10, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,867,949 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | ||
| US 10,709,844 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | ||
| US 11,684,723 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | ||
| US 12,623,027 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | ||
| US 8,814,834 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | ||
| Application 19/644,541 | Injector Safety Device Pending Not granted | Antares Pharma, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Antares Pharma, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.